Description
Hemorise 500 mg is an intravenous (IV) medication containing Ferric Carboxymaltose, a form of iron used to treat iron deficiency anemia in adults. This treatment is typically administered when patients are unable to tolerate oral iron supplements or when oral iron has proven ineffective. Ferric Carboxymaltose works by replenishing iron stores in the body, which are essential for producing hemoglobin and supporting red blood cell function. It is typically given via IV infusion, with the dosage determined by the patient's weight and severity of anemia. This treatment helps to rapidly restore iron levels and alleviate symptoms of anemia, such as fatigue, weakness, and shortness of breath. However, it is important to monitor for potential side effects such as headaches, dizziness, injection site reactions, or, in rare cases, more serious hypersensitivity reactions. Hemorise is generally recommended for use under healthcare supervision due to the need for proper dosage and monitoring during administration.
.png)
.jpeg)
.png)
.webp)
.jpeg)
.webp)
.png)
.webp)
.jpeg)
Change Language